Walleye Trading LLC Iovance Biotherapeutics, Inc. Call Options Transaction History

Walleye Trading LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$7.59 - $17.47 $194,304 - $447,232	25,600 New	25,600 $379,000
Q3 2023 Nov 14, 2023	SELL	$4.44 - $8.79 $18,204 - $36,039	-4,100 Reduced 7.79%	48,500 $220,000
Q2 2023 Aug 14, 2023	BUY	$5.36 - $9.06 $281,936 - $476,556	52,600 New	52,600 $370,000
Q1 2022 May 16, 2022	SELL	$12.38 - $19.1 $2,476 - $3,820	-200 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$16.55 - $27.63 $263,145 - $439,317	-15,900 Reduced 98.76%	200 $4,000
Q2 2021 Aug 16, 2021	SELL	$16.33 - $33.07 $636,869 - $1.29 Million	-39,000 Reduced 70.78%	16,100 $419,000
Q1 2021 May 17, 2021	BUY	$28.67 - $52.59 $1.58 Million - $2.9 Million	55,100 New	55,100 $1.74 Million
Q2 2020 Aug 14, 2020	SELL	$27.21 - $41.0 $1.07 Million - $1.62 Million	-39,500 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$19.54 - $38.85 $771,830 - $1.53 Million	39,500 New	39,500 $1.18 Million

319

243M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $923M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.